Related Experiment Video
Updated: Aug 9, 2026

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1
Lixin Zheng1, Nicolas Bidere, David Staudt
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH, 9000 Rockville Pike, 10/11D09, Bethesda, MD 20892, USA. lzheng@niaid.nih.gov
Abstract:
Stimulation of tumor necrosis factor receptor 1 (TNFR1) can initiate several cellular responses, including apoptosis, which relies on caspases, necrotic cell death, which depends on receptor-interacting protein kinase 1 (RIP1), and NF-kappaB activation, which induces survival and inflammatory responses. The TNFR-associated death domain (TRADD) protein has been suggested to be a crucial signal adaptor that mediates all intracellular responses from TNFR1. However, cells with a genetic deficiency of TRADD are unavailable, precluding analysis with mature immune cell types. We circumvented this problem by silencing TRADD expression with small interfering RNA. We found that TRADD is required for TNFR1 to induce NF-kappaB activation and caspase-8-dependent apoptosis but is dispensable for TNFR1-initiated, RIP1-dependent necrosis. Our data also show that TRADD and RIP1 compete for recruitment to the TNFR1 signaling complex and the distinct programs of cell death. Thus, TNFR1-initiated intracellular signals diverge at a very proximal level by the independent association of two death domain-containing proteins, RIP1 and TRADD. These single transducers determine cell fate by triggering NF-kappaB activation, apoptosis, and nonapoptotic death signals through separate and competing signaling pathways.
Insights
Tumor necrosis factor receptor 1 (TNFR1) signaling involves TRADD and RIP1 proteins. These proteins compete to determine cell fate, initiating either apoptosis or necrosis via distinct pathways.
Area of Science:
- Cellular biology
- Immunology
- Molecular signaling
Background:
- Tumor necrosis factor receptor 1 (TNFR1) triggers diverse cellular outcomes, including apoptosis, necrosis, and NF-kappaB activation.
- The TNFR-associated death domain (TRADD) protein is hypothesized as a key mediator of TNFR1 signaling.
- Lack of TRADD-deficient cells hindered direct analysis of its role in mature immune cells.
Purpose of the Study:
- To investigate the specific roles of TRADD and RIP1 in TNFR1-mediated cellular responses.
- To elucidate the mechanism by which TNFR1 signaling pathways diverge to induce distinct cell death programs.
Main Methods:
- Small interfering RNA (siRNA) was used to silence TRADD expression in cells.
- Analysis of TNFR1-initiated signaling pathways, including NF-kappaB activation, apoptosis, and necrosis.
- Investigated the competitive recruitment of TRADD and RIP1 to the TNFR1 signaling complex.
Main Results:
- TRADD is essential for TNFR1-induced NF-kappaB activation and caspase-8-dependent apoptosis.
- TRADD is dispensable for TNFR1-initiated, RIP1-dependent necrotic cell death.
- TRADD and RIP1 compete for binding to TNFR1, directing distinct downstream signaling events.
Conclusions:
- TNFR1 signaling diverges at the level of TRADD and RIP1 recruitment.
- These two proteins act as competing transducers, dictating cell fate decisions.
- TRADD and RIP1 independently control NF-kappaB activation, apoptosis, and nonapoptotic cell death pathways.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Regulation of the Unfolded Protein Response
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
